My work integrates scholarly research, public education, and social change activism. Projects in 2017 include a Lillian Robinson Visiting Scholar appointment at Simone de Beauvoir Institute in Montreal and a book, Health Advocacy Inc. (UBC Press). Both projects move into public discussion my ethnographic research on the policy implications of pharmaceutical company funding of patients' advocacy groups.

Batt, S. (2016), Pharmaceutical Company Corruption and the Moral Crisis in Medicine. Hastings Center Report. doi: 10.1002/hast.575 Batt S. (2015). A community fractured: breast cancer activism, pharmaceutical company funding and science-related advocacy in Canada. In P Wehling, W Viehöver and S Koenen (eds.), The Public Shaping of Medical Research: patient associations, health movements and biomedicine. Abingdon, Oxon and New York: Routledge. Batt S. (2014). Who will support independent patients groups. BMJ October 25, 2014, 349:g6306. Batt S. (2010). Who pays the piper? Industry funding of patients’ groups. In A Rochon Ford and D Saibil (eds), The Push to Prescribe: Women & Canadian Drug Policy, Toronto: Women’s Press/Canadian Scholars’ Press. Batt S. Patient no more: The politics of breast cancer, Charlottetown, Canada: Gynergy Books and London UK: Scarlet Press, 1994. Australia and New Zealand edition, Melbourne: Spinifex, 1996. French translation: À bout de patience: les enjeux de la lute au cancer du sein, Montréal: Remue-ménage, 1998.